Increased TRPC1 expression has been reported to contribute to pancreatic cancer cell motility, breast cancer, non-small cell lung cancer, colon cancer, and glioblastoma multiforme proliferation and migration [48,49,50,51,52]. Here, TRPC1 is linked to breast carcinoma.